textcdata record date 20610826 micu intern admit note internal medicine name goins jacob mr transfer linden health care center date admission 082561 full code contact information cchpi 27yo male cedar hill lakes nevada w history insulinrequiring dm previously follow cottage sanatorium admit linden health care center become unresponsive visit sister maryland report patient sit couch sister house slump floor seizure activity x 45seconds witnessed em sevices accuchecks do time 500 attempt intubation unsuccessful transport er additional attempt secure airway also unsuccessful 2 physician appear sot stricture upper airway obvious ct scan however pt witnessed emesis place 100 nonrebreather mask verse propofol sedation adequate o2 saturation xray confirm dependent lung infiltrates consistent aspiration pneumonia pt start clindamycin arrival er patient also find blood pressure 248146 receive 50mg dose labetolol er well several additional dos icu icu patient witness seizure activity head ct demonstrate focal lesion ic hemorrhage abnormality pt treat dilantin iv insulin infusion serum ketone negative additional workup reveal lvh ekg criterion well renal insufficiency cr 26 urine tox positive benzos otherwise negative patient also develop leukoytosis wbc temp 102 degree although minimal neck stiffness neurology consult exam underwent lumbar puncture demonstrate colorless clear fluid glucose 108 tp 44 gram stain negative tube 4 contain 21rbcs 7 wbc diff 96 pmns 4 lymph csf culture blood culture also do pending hospital course patient maintain adequate oxygenation nasal trumpet place abg 082561 736pco2 45 po2 366 bicarb 25 100 sat fio2 subsequently wean remain hemodynamically stable bp 18488 map 114 hr100 rr23 97 cannula cardiac enzyme negative patient mother arrive georgia request transfer bmh report history hypertension seizure disorder mother report patient occasional spell past last 510minutes patient would become non communicative associate elevate glucose pmh 1 insulin dependent dm diagnose age 12 follow cottage sanatorium pcp regular care time medication admission 1 labetolol 20mg iv q1hr prn map120 2 ativan 12mg iv q1h prn 3 insulin gtt currently 4uhr 4 clindamycin 600mg iv q6h aspiration pneumonitis 5 pepcid 20mg iv qd 6 dilantin 100mg iv q8h 7 iv ntg 5mcgmin transfer allergy nkda per osh soc hx live mother waycross work store unclear type leave home smoke drinking binge report mother associates several group friend mother aware drug use also rule fh htn mother father exam v 99 hr 92 bp 18280 rr 20 o2sat 9598fio2 ra general respond localizes pain move extremity heent ncat pupil small reactive eye conjugate chest cta b cv s1 s2 s3 murmur abd bs soft nontender nondistended subcutaneous indurated tissue mid leave upper abdomen 4x5cm extr normal bulktone multiple round dark lesion right arm indurate 3x4cm subcutaneous area bilateral thigh anteriorly edema ble 2dp data 082561 unspecified ph 742 732745 unspecified pco2 35 3550 mmhg unspecified po2 74 4090 mmhg wbc 226 h 45110 thcmm hct 421 410530 hgb 140 135175 gmdl rbc 503 450590 milcmm plt 677 h 150350 thcumm mcv 84 80100 fl mch 278 260340 pgrbc mchc 333 310370 gdl rdw 122 115145 pt 134 h 113133 sec aptt 261 221351 sec poly 82 h 4070 lymph 10 l 2244 monos 7 411 eos 1 08 basos 0 03 absolute neuts 1854 h 1877 thcmm absolute lymphs 231 1048 thcmm absolute monos 156 h 0204 thcmm absolute eos 012 0103 thcmm absolute basos 007 0003 thcmm aniso none normal hypo none normal macrocytes none microcytes none sodium stat lab 145 135145 mmoll potassium stat lab 32 l 3448 mmoll chloride stat lab 117 h 100108 mmoll co2 stat lab 255 230319 mmoll bun stat lab 21 825 mgdl creatinine stat lab 25 h 0615 mgdl glucose stat lab 233 h 70110 mgdl calcium 89 85105 mgdl phosphorus 18 l 2645 mgdl plasma lactic acid 25 h 0522 mmoll magnesium 21 h 1420 meql total protein 70 6083 gdl albumin 27 l 3350 gdl globulin 43 h 2641 gdl direct bilirubin 02 004 mgdl total bilirubin 11 h 0010 mgdl triglycerides 118 40150 mgdl cholesterol 307 mgdl high density lipoprotein 85 35100 mgdl alkaline phosphatase 81 45115 ul transaminasesgpt 27 1055 ul amylase 222 h 3100 unitsl lipase 14 1360 udl creatine kinase isoenzymes 60 0069 ngml cpk isoenzymes index 01 0035 troponint 004 000009 ngml transaminasesgot 81 h 1040 ul creatine kinase 7511 h 60400 ul phenytoin dilantin 91 50200 mcgml uacolor amber yellow uaturbidity turbid clear uaglucose 3 neg uabili negative neg uaketones trace neg uaspecific gravity 1027 10011035 uaoccult blood 3 neg uaph 60 5090 uaalbumin 3 neg uaurobilinogen negative neg uanitrite negative neg uawbc screen trace neg uasedrbc pack 02 hpf uasedwbc 50100 02 hpf uasedbacteria moderate neg hpf hyaline cast 02 05 lpf squamous cell many neg hpf uric acid crystal many neg hpf microscopic sediment complete ekg nsr borderline lvh cxr perihilar opacity ow clear assessment plan 27yo ho insulin dependent dm medically follow pw witnessed seizure episode context severe hypertension 1 neuro seizure episode unresponsiveness non localize neuro exam concern hypertensive encephalopathy pt lp outside hospital suggest meningitis possibility include infarct encephalitis neurology consult recommendation n eeg n mri w susceptibility evaluate posterior leukoencephalopathy mra headneck mrv brain n dilantin continue osh n check tox screen ammonia mother bring unknown pill try identify 2 id increase wbc low grade temp sp lp bacterial source cxr opacities suspicious pneumonia start vancomycin cefepime empirically narrow per culture result concern encephalitis hsv present w htn seizures ask linden health add hsv pcr csf take lp prior transfer start acyclovir empirically interim 3 resp sp multiple attempt intubation osh currently breathe adequately ra audible obstructive physiology give need mri may sedate intubate call anesthesia continue intubate m alert airway protection start ardsnet criterion meet low pao2fio2 ratio bilateral pulmonary infiltrates 4 cv severe hypertension w evidence potential end organ damage kidneybraincardiac control bp w nipride drip addition labetalol hr control target goal 25 decrease spb160 today sbp 120 follow day check cktpns continue ivf potential rhabdo 5 renal renal failure w cr 26 unclear baseline suspect acute chronic component give dm w poor followup check urine sediment lytes evaluate reading hyalinewaxy cast wbc rbc cast kidney u pending also doppler evaluate ra also check urine reninaldo 24hr metanephrine pheochromocytoma serum metanephrine 24hr protein nephritic syndrome presence htn hematuria 6 endo tight glucose control czi drip dm gap ketone osh arrive dka need reg insulin drip dcd future 7 access piv 8 prophylaxis nexium heparin sq peridex hob 30 infant ledford 12182 record date 20611003 bmh cancer center hematology note fellow james tyler attend cole morgan date consultation october 04 2061 diagnosis thrombocytosis reactive v essential thrombocytosis hpi 27 yo african american male recent complicate hospital stay bmh present hematology clinic first time follow thrombocytosis 27 yo male history type dm get regular medical care late august visit family maryland sudden witness seizure activity time blood sugar 500 upon initial arrival er maryland bp 248146 plt count 800s patient intubate treated htn labetolol place iv insulin dilantin transfer bmh care bmh mri show several small area infarct read concern embolic cva echo do show vegetation pfo nl ef lvh tee without vegetation well lp do sent hsv negative underent renal workup show nephrotic range proteinuria lab also show rhabdoymyolysis renal doppler u show sign ra continue abx aspiration pna part secondary htn workup do include evaluation hyper aldo pheo vent wean extubated 4th htn control labetolol drip additional oral agent add continued intermittent fever broad antibiotic originally wean hematologically hct wbc fell hydrate plt count stay stable 600s several day increase 3rd gradually 1000 retics depressed presentation iron study cw acd start epogen initially felt thrombocytosis certainly reactive crp 150 esr 100 leave icu point wbc trend afebrile clinically stable platelet keep climb nearly 15 million bone marrow biopsy do show cytogenetics suggest cml elevate megakaryocyte read concern myeloproliferative process well suffer dvt subclavianij side central venous catheter give thrombocytosis elevate plt count platelet pheresed twice hospital well hydrea start time initially 500mg bid escalate 1000mg bid count 800900 despite medication well suffer small gi bleed due ulcer reason anticoagulated place upon daily asa discharge hospital two week ago do fairly well since energy good denies feverschillssweats bleedingbruising swell armslegs occasionally blurryness eye immediately take antihypertensive numnbessweaknessdizziness problemspmh dm type 1 since age 12 recollection abnormal blood count prior admit new diagnosis admit renal insufficiency nephrotic proteinuria malignant hypertension thrombocytosis gi bleed upper ulcer visualize egd small embolic appear cva medication diovan lisinopril hydrea 1000 bid asa 81 qod lopressor procardia clonidine nexium insulin 25 regular34 nph pm 20 regular28 nph allergy nkda social history life waycross single work geologist tob report social etoh family history htn physical examination vital sign bp 10163 p 64 rr 16 temp 981 f wt 202 lb gen wellappearing male alert conversant nad heent supple nonicteric cervicalsupraclav adenopathy chest clear cv reg abd benign hsm ext trace le edema upper edema skin scatter ulceration arm granulation tissue scar vesicular change neck data 10032061 wbc 41 l rbc 395 l hgb 120 l hct 355 l mcv 90 mch 304 mchc 338 plt 601 h 10032061 rdw 172 h 10032061 diffr receive method neut 57 lymph 36 mono 3 l eos 3 baso 1 10032061 aneut 235 alymp 148 amon 010 l aeosn 010 abasop 002 10032061 retic 10 assessment plan interest case 27 yo male insulin dependent diabetes apparent untreated htn present seizure set hypertensive emergency find nephrotic syndrome renal insufficiency several small embolicappearing stroke develop mark thrombocytopenia 15 million subsequent provoke dvt treat concern essential thrombocytosis hospital platelet pheresis hydrea today present look well still thrombocytosis despite hydrea still possible tell sure still reactive thrombocytosis v essential thrombocytosis moment continue treat et continue hydrea current dose ask take aspirin 81 mg qd reactive process time good diagnostic test improve complicate hospitalicu stay next visit u next month recheck creactive protein esr iron studiesferritin idea whether body could still mount inflammatory response drive reactive thrombocytosis plt count come able start taper hydrea time note near future may able help determine reactive essential process measurement jak2 kinase level meantime meet new pcp renal physician next week james b tyler md record date 20620327 hematology clinic progress note fellow inge logan md attend cole morgan md phd date visit march 27 2062 diagnosis mr goins 27 yom thrombocytosis interval followup hydrea hematologic history mr goins 27 yo male history type dm formally without regular medical care visit family maryland sudden witness seizure activity late august time blood sugar 500 upon initial arrival er maryland bp 248146 plt count 800s patient intubate treated htn labetolol place iv insulin dilantin transfer bmh care bmh brain mri show several small area infarct read concern embolic cva embolic workup include echo show vegetation pfo nl ef lvh tee without vegetation well lp do sent hsv negative underwent renal workup show nephrotic range proteinuria lab also notable rhabdoymyolysis renal doppler u show sign ra continue abx aspiration pna part secondary hypertensive workup do include evaluation hyperaldosteronism pheochromocytoma vent wean extubated 4th htn control labetolol drip additional oral agent add continued intermittent fever broad antibiotic originally wean hematologically hct wbc fell hydrate plt count stay stable 600s several day increase 3rd gradually 1000 retics depressed presentation iron study cw acd start epogen initially felt thrombocytosis certainly reactive crp 150 esr 100 leave icu point wbc trend afebrile clinically stable platelet keep climb nearly 15 million bone marrow biopsy do show normal cytogenetics evidence cml bone marrow demonstrate elevate megakaryocyte concern myeloproliferative process well suffer dvt subclavianij side central venous catheter give thrombocytosis elevate plt count platelet pheresed twice hospital well hydrea start time initially 500mg bid escalate 1000mg bid count 800900 despite medication well suffer small gi bleed due ulcer reason anticoagulated place upon daily asa discharge hospital september since follow hematology clinic initially platelet still hi 500 despite hydrea 1000 bid hematocrit mildly depress point well 2931 reevaluate 120561 platelet 502000 epo level draw hydrea increase 15001000mg reevaluate 122661 find hematocrit 262 wbc 27k platelet 508000 hydrea decrease 500mg bid interval history since last visit leave wynne one month return creatinine increase 40 renal biopsy perform last week show diabetic nephropathy evaluate dr xing dialysis renal transplant evaluation term blood disorder patient baseline fatigue slightly improve past month fever chill night sweat unexplained weight loss one episode transient global blurry vision 3 week ago resolve recurred headache sensory deficit focal neurologic symptom oral ulcer skin lesion hydrea problem diabetes mellitus type 1 nephrotic syndrome malignant hypertension thrombocytosis unclear secondary v essential renal insufficiency cerebrovascular accident embolic unclear source set high platelet count unspecified gi bleed medication hydrea hydroxyurea 500 mg 500mg capsule take 1 po bid asa acetylsalicylic acid 81 mg 81mg tablet take 1 po qd nexium esomeprazole 40 mg 40mg capsule dr take 1 po bid nifedipine sustain release 90 mg 90mg tablet take 1 po qd humulin n insulin nph human 40 unit sc qam humulin n insulin nph human 36 unit sc qpm insulin regular human 25 unit sc qam insulin regular human 20 unit sc qpm lasix furosemide 40 mg 40mg tablet take 1 po qd lisinopril 40 mg 40mg tablet take 1 po qd toprol xl metoprolol succinate extend release 100 mg 100mg tabsr 24h take 1 po bid allergy nkda social history life waycross single work geologist work tobacco denies etoh social illicits denies family history hypertension mother father father severe htn well renal disease though dialysis review system generalize weakness fatigue able walk short distance stable denies chill night sweat negative shortness breath chest pain palpitation cough sputum production sore throat epistaxis gingival bleed nausea vomit anorexia diarrhea constipation hematochezia melena hematuria urinary symptom ros negative detail physical examination vital sign bp 12884 p 68 rr 16 temp 986 f wt 218 lb gen thin male alert conversant nad heent supple anicteric cervicalsupraclav adenopathy mild proptosis chest ctap without wheeze rub cv rrr s1s2 s4 mrg abd benign hsm ext trace le edema upper edema cyanosisclubbing skin scatter ulceration arm granulation tissuestable scar vesicular change neck neuro aox3 able ambulate without difficulty data see lmr assessment plan mr goins 27 yo male insulin dependent diabetes apparent untreated htn present seizure set hypertensive emergency subsequently find nephrotic syndrome renal insufficiency several small embolicappearing stroke set develop mark thrombocytosis 15 million subsequent provoke dvt treat platelet pheresis hydrea unclear still reactive thrombocytosis v essential thrombocytosis follow cbc hydrea platelet moderately elevate 757k evidence recurrent thrombosis current hydrea dosing increase due anemia would advise start erythropoetin monitoring blood pressure closely current platelet count risk thrombosis greatly increase especially platelets dysfunctional due uremia would advise continue current hydrea continue current hydrea monitor count monthly agree start erythropoetin internal medicine return 4 month followup count patient see discuss dr morgan inge j logan md record date 20620530 internal medicine barton memorial hospital history present illness followup visit 28yearold black man medical problem type 1 diabetes mellitus hypertension thrombocytosis chronic renal insufficiency patient state since last saw evaluate renal transplant addition attempt make place av fistula dialysis right arm work give one work decision make wait see transplant candidate get renal transplant rather put piece place hemodialysis fact would need recently patient creatinine 64 bun 46 two week ago major problem diabetes mellitus type 1 diabetes mellitus patient diabetes currently well control current regimen nph regular insulin recently hemoglobin a1c 66 02272062 patient state fingersticks home consistently 70 110 chronic renal insufficiency patient evaluate renal transplant possible candidate family member friend test see whether match shortly hypertension patient tremendous amount medication treat hypertension currently labetalol 600 mg po bid furosemide 20 mg po qd clonidine 03 mg po qhs lisinopril 40 mg po qd nifedipine xl 90 mg po qhs bhypertension currently well control regimen erectile dysfunction patient experience erectile dysfunction largely toprol reason toprol discontinue patient less problem issue currently anemia patient anemia due multiple different factor recently start erythropoietin get via injection internal medicine three time week recently hematocrit 294 two week ago thrombocytosis patient hydria 500 mg po qd problem follow hematology hyperlipidemia patient hyperlipidemia new recently lipids do 02272062 time total cholesterol 294 ldl 209 new problem patient give lipid fairly normal six month ago give patient start lipitor 20 mg po qd hyperlipidemia repeat lipid panel time next visit eight week active medication aspirin 81mg po qd clonidine 03mg po 1 tab po q pm furosemide 20 mg po qd humulin n 40 unit qam sc 36 unit qpm take 3060min meal h hydrea 500mg po bid insulin syringe u 100 labetalol hcl tablet 600 mg po bid lancets lipitor 20mg po qd lisinopril 40mg po qd nexium 40mg po bid take 1h meal nifedipine xl 90mg sr po qhs cutcrushchew onetouch test strip potassium chloride 10meq po qd regular insulin 25 unit qam sc 20 unit qpm give 3060min meal change therapy renewal hydrea 500mg po bid qty60 refills5 start 10162061 toprol xl 100 mg po bid qty30 refills5 start 10162061 end 5302062 inactivated furosemide 20 mg po qd qty30 refills5 start 10162061 labetalol hcl tablets 600 mg po bid qty60 refills5 start 05302062 lipitor 20mg po qd qty30 refills5 start 05302062 physical examination blood pressure 12088 weight 215 pound general appearance welldeveloped wellnourished black man distress chest lung clear throughout aandp cor regular rate rhythm murmur rub gallop select recent lab fingerstick blood sugar 75 disposition patient follow six eight week note transcribed outside service transcription error may present sign electronically ali felicia jun 6 2062 record date 20620830 ccu jar admit note name jacob goins mr 6850327 please note pt also mrn 4033790 date admission 8302062 resident addison keefe attend angel vail pcp felicia ali source medical record family cc l arm weakness hpi 28 yo rh ho dm1 esrd hd htn stroke think due thrombocytosis gtc set htn one year ago june per family multiple htn episodes many antihypertensive rij thrombosis transient l arm weakness hd follow difficulty speak change mental status reportedly good health night prior admission morning admission per family sick contact travel hd hypertensive sbp 200s transient l arm weakness paresthesia resolve difficulty speak follow command noted nephrologist osh mentating well normal speech urinarybowel incontinence tonicclonic movement syncope noted provider bring bmh ed problem ed initial v bp 211120 hr 88 98 r 18 sao2 100 ra receive head ct show acute infarct ich mri show acute infarct dwi agitate scanner could complete study receive 5 mg hydralazine iv x 2 start first tng gtt nitroprusside gtt 100min titrated goal map 120 bp 251104 2315 l arm weakness resolve agitate transiently want leave ama admitted ccu management ro per hpi system negative detail pmh thrombocytosis 1 follow dr morgan bmh 1 jak2 mutation myeloproliferative wu 2 high ferritin low tibc high esr level check past 3 hydrea b esrd due dm1 htn 1 biopsy 362 advance diabetic glomerulopathy secondary fsgs 2 r avg 704 hd x 1 month 3wk 3 evaluate transplant c dm1 since age 11 1 hgba1c 76 762 2 repeat hypoglycemic episode past 3 hx dka htn e hyperlipidemia f anemia g gtc august last year per family report june year attribute htn briefly dilantin dcd due side effect h mri embolic focus august 2061 1 wu prove negative attributed thrombophilia medication admission aspirin 81mg po qd clonidine 03mg po 1 tab po q pm diovan 320mg po qd furosemide 20 mg po qd humulin n 35 unit qam sc 25 unit qpm hydrea 500mg po bid insulin syringe u 100 labetalol hcl tablet 600 mg po bid lancets lipitor 40mg po qd lisinopril 40mg po qd nephrocaps 1 po q nexium 40mg po bid nifedipine xl 90mg sr po qhs onetouch test strip potassium chloride 10meq po qd regular insulin 25 unit qam sc 20 unit qpm nkda sh live mother used work bebo geologist currently unemployed etoh illicits tobacco fh htn parent mother stroke father hd dm1 dm2 ckd family member physical exam v 999 bp 21090 p 110 r 20 sao2 100 ra gen wdwn american male follow command intermittently heent ncat perrl eomf sclera anicteric neck supple thyromegaly carotid bruits jvp flat node cervical supraclavicular lan cor tachy rr s1 s2 nl mrg s3 prominent pmi chest ctab anteriorly abdomen bs soft nt nd hsm cva tenderness l paraumbilical bruit pulsatile mass ext cce warm wellperfused subcutaneous mass anterior r thigh r av fistula thrill 3 dp pt pulse bl indwell l arterial line skin rash neuro x 1 perrl eomf smile symmetric sensation grossly intact light touch strength 55 flexion extension upper low extremity reflexes 2 toe downgoing labs study chemistry lytesrenalglucose sodium 136 135145 mmoll 082962 1713 potassium 35 3448 mmoll 082962 1713 chloride 99l 100108 mmoll 082962 1713 99l 082962 1713 carbon dioxide 306 230319 mmoll 082962 1713 bun 24 825 mgdl 082962 1713 creatinine 50h 0615 mgdl 082962 1713 50h 082962 1713 glucose 91 70110 mgdl 082962 1713 general chemistry bilirubin 08 0010 mgdl 082962 1745 bilirubin di 03 004 mgdl 082962 1745 total protein 80 6083 gdl 082962 1745 albumin 38 3350 gdl 082962 1745 globulin 42h 2641 gdl 082962 1745 42h 082962 1745 liver function test alt sgpt 11 1055 ul 082962 1745 ast sgot 29 1040 ul 082962 1745 alk phos 76 45115 ul 082962 1745 bilirubin 08 0010 mgdl 082962 1745 bilirubin di 03 004 mgdl 082962 1745 hematology complete blood count wbc 149h 45110 thcmm 082962 1712 149h 082962 1712 rbc 388l 450590 milcm 082962 1712 388l 082962 1712 hgb 143 135175 gmdl 082962 1712 hct 412 410530 082962 1712 mcv 106h 80100 fl 082962 1712 106h 082962 1712 mch 368h 260340 pgrbc 082962 1712 368h 082962 1712 mchc 347 310370 gdl 082962 1712 plt 839h 150350 thcumm 082962 1712 839h 082962 1712 rdw 171h 115145 082962 1712 171h 082962 1712 blood differential differential receive 082962 1709 diff method auto 082962 1713 neutrophil 88h 4070 082962 1713 88h 082962 1713 lymph 8l 2244 082962 1713 8l 082962 1713 mono 3l 411 082962 1713 3l 082962 1713 eos 1 08 082962 1713 basos 0 03 082962 1713 blood diff absolute neutrophil 1314h 1877 thcmm 082962 1713 1314h 082962 1713 lymph 116 1048 thcmm 082962 1713 mono 045h 0204 thcmm 082962 1713 045h 082962 1713 eos 009l 0103 thcmm 082962 1713 009l 082962 1713 baso 003 0003 thcmm 082962 1713 smear morphology anisocytosis 1h none 082962 1713 1h 082962 1713 hypochromia none none 082962 1713 macrocyte 3h none 082962 1713 3h 082962 1713 microcyte none none 082962 1713 coagulation routine coagulation pt 121 111136 sec 082962 1726 ptinr 10 082962 1726 ptt 249 221340 sec 082962 1726 toxicology ephedrine hypercoagulation study act prot c 25 20 091261 1420 protein fu 112 70140 091261 1420 protein c fu 160h 70140 091261 1420 160h 091261 1420 homocysteine refuse 012 umoll 091261 0608 at3 nl act 108 80130 091261 1420 interpretatio see detail 91461 1831 antiphospholipid antibody cardiolipin 47 015 gpl 072562 1234 cardiolipin 130 015 mpl 072562 1234 ekg sinus tachycardia 110 nonspecific anterior st abnormality unchanged 71362 head ct evidence acute intracranial process mri acute infarct dwi pt complete study mra pelvis 82862 1 patent abdominal aorta visceral vessel 2 patent aortoiliac system 3 right patent arterial tree 4 leave patent arterial tree renal ultrasound doppler 82661 evidence hydronephrosis slightly echogenic kidney trace free fluid ap 28 yo man dm1 esrdhd htn hyperlipidemia thrombocytosis hypertensive emergency bp remain high attempt reduce 25 map hour start oral agent nitroprusside use first need extend treatment change nicardipine bj q sugudoyta 1165 glb79 kk 14148 give esrd change mental status likely due hypertensive encephalopathy hard exclude source endorgan involvement heart especially consider thrombocytosis give ongoing confusion source confusion might include meningitis give leukocytosis 1 cv pump s3 sign l r heart failure ii reduce afterload prog b rhythm sinus tachycardia give ivfs reduce highreninemic natriuretic state c ischemia ekg change consistent ischemia cycle cardiac biomarkers x 3 give asa lipitor ii reduce afterload nitroprusside ivfs po antihypertensives 2 neuro mental status leukocytosis likely due hypertensive encephalopathy potentially concern possible meningitis perform lumbar puncture hold abx since hospital 6h give csf study indicate b neuro follow 3 htn reduce map 25 100 start nitroprusside switch nicardipine restart oral agent reduce 4 dm1 start halfdose insulin nph cover riss 5 renal need hd consult renal 6 thrombocytosis stable consult dr morgans team continue hydroxyurea 7 access l arterial line peripheral iv 8 fen ivfs start oral diet mental status improve 9 heme baseline anemia likely currently hemoconcentrated montor hct 10 prophylaxis senna colace nexium heparin name addison keefe md phd pager 92783 pgy2 text 